Cargando…
Use of Topical Rapamycin in Facial Angiofibromas in Indian Skin Type
INTRODUCTION: Facial angiofibromas (FA) are the most visible cutaneous manifestations in patients with tuberous sclerosis (TS), often resulting in stigmatization of the affected individuals. Recent studies have suggested that topical rapamycin may be an effective treatment for angiofibromas. AIM: To...
Autores principales: | Viswanath, Vishalakshi, Thakur, Parul, Pund, Poonam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763637/ https://www.ncbi.nlm.nih.gov/pubmed/26951710 http://dx.doi.org/10.4103/0019-5154.174087 |
Ejemplares similares
-
Topical rapamycin (sirolimus) for facial angiofibromas
por: Madke, Bhushan
Publicado: (2013) -
Topical rapamycin for facial angiofibromas in tuberous sclerosis complex
por: Safa, Gilles
Publicado: (2017) -
Erythema Dyschromicum Perstans: Response to Topical Tacrolimus
por: Mahajan, Vikram K, et al.
Publicado: (2015) -
Facial Angiofibromas of Tuberous Sclerosis Treated with Topical Sirolimus in an Indian Patient
por: Vasani, Resham J
Publicado: (2015) -
Topical Corticosteroid Misuse: The Indian Scenario
por: Coondoo, Arijit
Publicado: (2014)